Jun 08, 2021 7:05am EDT Independent Proxy Advisory Firms Recommend IMV Shareholders Vote for All Director Nominees at the Upcoming Annual General and Special Meeting
May 12, 2021 7:05am EDT IMV Inc. Announces First Quarter 2021 Financial and Operational Results and Expansion of its Clinical Pipeline
Apr 29, 2021 7:05am EDT IMV Inc. to Announce First Quarter 2021 Results and Host a Conference Call and Webcast on May 12, 2021
Apr 13, 2021 7:05am EDT IMV Inc. to Present at the Bloom Burton & Co. Healthcare Investor Virtual Conference
Apr 07, 2021 7:05am EDT IMV Announces Company-Sponsored Clinical Trial in Patients with r/rDLBCL in Collaboration with Merck Following Feedback from FDA
Mar 17, 2021 7:05am EDT IMV Inc. Announces Fourth Quarter and Full Year 2020 Financial and Operational Results
